1987
DOI: 10.1001/archderm.123.2.191
|View full text |Cite
|
Sign up to set email alerts
|

Mast cells and fibrosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

1988
1988
2018
2018

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 14 publications
(4 citation statements)
references
References 0 publications
0
4
0
Order By: Relevance
“…Keloids and hypertrophic scars both contain high numbers of mast cells (Boyadjiev et al , 1995; Hakanson et al , 1969; Harunari et al , 2006; Kischer et al , 1978; Smith et al , 1987), and recently, the mast cell stabilizer ketotifen was shown to reduce contraction and scar tissue deposition in a hypertrophic scar model (Gallant-Behm et al , 2008). Mast cells are also thought to contribute significantly to fibrotic diseases in the skin and other organs, such as scleroderma and pulmonary fibrosis (Atkins and Clark, 1987; Gruber, 2003). Overall, the data presented here provide further evidence that mast cells could be a viable target for anti-fibrosis and anti-scarring therapies.…”
Section: Discussionmentioning
confidence: 99%
“…Keloids and hypertrophic scars both contain high numbers of mast cells (Boyadjiev et al , 1995; Hakanson et al , 1969; Harunari et al , 2006; Kischer et al , 1978; Smith et al , 1987), and recently, the mast cell stabilizer ketotifen was shown to reduce contraction and scar tissue deposition in a hypertrophic scar model (Gallant-Behm et al , 2008). Mast cells are also thought to contribute significantly to fibrotic diseases in the skin and other organs, such as scleroderma and pulmonary fibrosis (Atkins and Clark, 1987; Gruber, 2003). Overall, the data presented here provide further evidence that mast cells could be a viable target for anti-fibrosis and anti-scarring therapies.…”
Section: Discussionmentioning
confidence: 99%
“…Mast cells, which derive from CD34-positive bone marrow stem cells, produce and liberate a variety of biologically active agents, especially monoamines such as histamine. They appear to participate in a variety of inflammatory dermatoses and in some tumors (Atkins and Clark 1987; Melman 1987; Longley et al 1995; Maurer et al 1997; Tada et al 2000). Corresponding to our finding that VMAT2 is present in all cutaneous mast cells of the primate skin, observations in knockout mice lacking the VMAT2 isoform have shown that the quantal release of histamine and serotonin from mast cells is mediated by VMAT2 (Travis et al 2000).…”
Section: Discussionmentioning
confidence: 99%
“…MCs have been identified in human liver, and it has been reported that their numbers increase during the course of hepatic diseases associated with excessive extracellular matrix (ECM) deposition (1,2,4,7,15,18,22,23). Increased hepatic MCs have also been observed in a variety of experimental models of rat liver fibrosis (1), including fibrosis induced by porcine serum, radiation, bile duct resection and carbon tetrachloride (CCl 4 ).…”
Section: Introductionmentioning
confidence: 99%